FDA Center for Drug Evaluation and Research - What's New 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.QuVa Pharma, Inc. - 675685 - 01/26/2024
Compounding Pharmacy/Adulterated Drug Products (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 13, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Ningbo Poplar Daily-Use - 669486 - 02/05/2024
CGMP/Finished Pharmaceuticals/Adulterated (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 13, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Madhu Instruments Private Limited - 659694 - 02/01/2024
CGMP/Finished Pharmaceuticals/Adulterated (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 13, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Battle Creek Co-op/CHS, LLC dba Progressive Nutrition - 652732 - 08/14/2023
CGMP/Hazard Analysis/Risk-Based Preventive Controls for Food for Animals (PCAF)/Adulterated (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 13, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
CDER Exclusivity Board
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 13, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
OMUFA Performance Reports
Over-the-Counter Monograph Drug User Fee annual performance reports to Congress (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 12, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA ’s Implementation of Drug Supply Chain Security Act (DSCSA) Requirements
Drug Supply Chain Security Act (DSCSA) Implementation Plan (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 12, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Use of Data Monitoring Committees in Clinical Trials
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 12, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA Roundup: February 9, 2024
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Fiscal Year 2024 Generic Drug Science and Research Initiatives Public Workshop - 05/20/2024
The purpose of the public workshop is to provide an overview of the status of science and research initiatives for generic drugs and an opportunity for public input on these initiatives. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
CDER Communications Testing: Optimizing Drug Information Through Target Audience Feedback
Social and behavioral scientists in CDER ’s Office of Communications (OCOMM) collect feedback from target audience members on a variety of drug-related messages and information to help make sure the groups understand the communications shared with them. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 8, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
CDER ’s OGD and EMA’s Parallel Scientific Advice Pilot Program for Complex Generics Works to Increase Harmonization and Bring Generic Drugs to Patients
Pilot program works to increase harmonization and bring generic drugs to patients (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 8, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA and EMA Launch Parallel Scientific Advice Pilot Program for Complex Generics
Pilot program works to increase harmonization and bring generic drugs to patients (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 7, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Tianeptine
FDA alerts and notices regarding tianeptine (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 6, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA Roundup: February 6, 2024
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 6, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
